Pharmacological and Somatic Treatments for First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines
The VA/DOD guideline panel developed 15 pharmacological and somatic treatment recommendations to promote optimal, evidence-based care for active service members and Veterans. However, there remain multiple treatment planning decision points for which there is a lack of data and/or effective treatments.
Authors
- James Reston (ORCID: https://orcid.org/0000-0003-4997-3754)
- Fuad Issa (ORCID: https://orcid.org/0000-0002-9081-6841)
- Ira R. Katz (ORCID: https://orcid.org/0000-0002-1820-4090)
- Rachael Coller
- Shannon C. Ford
- Matthew A. Fuller (ORCID: https://orcid.org/0000-0002-9404-1713)
- Jennifer Ballard‐Hernandez (ORCID: https://orcid.org/0000-0003-1657-1476)
- Noosha Niv
- James Sall (ORCID: https://orcid.org/0000-0001-8564-1314)
- Robert W. Buchanan
- Richard A. Goldberg
Institutions
- ECRI Institute (US)
- University of Maryland, Baltimore (US)
- United States Department of Veterans Affairs (US)
- University of California, Los Angeles (US)
- Defense Health Agency (US)
- Walter Reed National Military Medical Center (US)
- Mann-Grandstaff VA Medical Center (US)
- Mental Illness Research, Education and Clinical Centers (US)
- Baltimore VA Medical Center (US)
- VA Long Beach Healthcare System (US)
Publication Details
- Journal
- Schizophrenia Bulletin
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1093/schbul/sbaf053
- Citations
- 2
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- U.S. Department of Veterans Affairs